Clearpoint Neuro rises as preliminary quarterly revenue beats estimates

Clearpoint Neuro

09/01/2024 11:16

** Shares of Clearpoint Neuro  CLPT.O  rise 10.1% to $6.95
premarket
    ** Late Monday, co posted preliminary Q4 rev of $6.8 mln
that beat Wall Street estimates of $6.22 mln - LSEG
    ** Medical device maker sees its 2024 rev between $28 mln
and $32 mln vs avg of analysts' estimates of $30.4 mln
    ** CLPT stock fell 19.8% in 2023

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))